TrialAdvances in therapy2025

Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study.

Xia Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.